Clinical Trial Update: Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers [Phase 4]

View source ↗

Summary

Phase 4 trial update on high-dose oral rabeprazole for preventing recurrent bleeding after endoscopic treatment of bleeding peptic ulcers; the study was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Bleeding
• Peptic Ulcer Disease

Drugs mentioned

• Rabeprazole (rabeprazole)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Peptic Ulcer Hemorrhage | Phase 4 | Status: TERMINATED | Results posted: 2010-09-24